Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
about
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomasOlig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant gliomaIdentification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells.The Olig family affects central nervous system development and diseaseAnti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomasNG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms.Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biologyMolecular pathogenesis of oligodendroglial tumors.Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.Olig gene function in CNS development and disease.Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.Molecular neuropathology of gliomas.Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.Long-term epilepsy-associated tumors.Proceedings of the 2016 National Toxicology Program Satellite Symposium.Molecular mechanisms of OLIG2 transcription factor in brain cancer.Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.Retinal astrocytoma in a dog.Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors.Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis.Predominant expression of OLIG2 over ID2 in oligodendroglial tumors.Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.Cerebral astroblastoma in an adult: an immunohistochemical, ultrastructural and genetic study.Papillary glioneuronal tumor: a clinicopathological and immunohistochemical study of two cases.In vitro identification and functional characterization of glial precursor cells in human gliomas.Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
P2860
Q28267034-26B28514-2B49-4074-BDEB-F9B4206B81E0Q28287898-3E5D42A6-8F53-403F-B4E2-68600A63193AQ30868592-0D1F227A-8DD4-4F2B-89D4-46CBA58502EFQ33270525-79B9DEDB-779D-4114-91D7-C6739809BA9BQ33571714-3AD507B9-489A-4F6F-8091-0CCCB31B21BBQ33770410-3160DB90-3F5A-42E4-BC32-12C13EA1A4A0Q34095604-B6FF2D08-37F7-4D7D-8F09-4B7D20372FBDQ35098051-3DEC19BA-28F0-4C2F-9D41-3DD4E64D71E1Q35133431-D2600C63-D320-4DD3-9761-F530A9F9C944Q35179617-516775E8-3B19-4271-A51A-50A4E900F64EQ35214798-CA047E46-071A-4CF1-B63F-BF63D5B7D521Q35558022-4E21B5F4-E0A9-448B-9C61-9F1BFDA65E9FQ36021563-6236B0F5-00FB-4632-B206-5EA741DF8A5AQ36348529-793F0647-78E7-482D-8E9C-B0D895BFE1E7Q36465466-62897DED-43D0-49BA-8D19-CB03CD28B6A5Q37069461-FE701ACE-E78C-4DAF-9B82-610CAD103314Q37427424-EDD54D19-5B0E-4F35-A2E3-B9544A525610Q37729676-89FF1642-3091-456E-8473-F958DCCA6AAAQ38002123-2E094A47-9096-460A-A2C1-3B16279838FAQ39207443-D7DA8326-1458-447F-8387-934D46E61029Q41810203-6688BF0D-02E6-4458-8DAA-FF06D8A8BEE2Q47592896-956911C3-89FE-4BAA-8290-E7AB521EDDCFQ47845527-D88FF889-A99E-4178-B5BB-5FA5268FA633Q48025289-7F7A2772-24A7-424D-8357-5503715EB846Q48198632-12CE5353-3AF7-4C1C-A780-556B8CD1CA4EQ48204854-A3BFAA9C-7FF0-431E-98F6-44DD16CB64A6Q48213398-123BA63B-3F06-4A33-B5F9-33FF8912B963Q48369469-069CF110-73A5-4639-8081-4EAA554571F6Q48498346-2D313B89-F59D-4C2F-BB07-441056E6895BQ48591268-5B601FC6-E49C-41CB-9F4A-E76125893AA3Q48743716-02F02AB0-863F-4754-BD1F-A4A2411C6A5CQ55471329-72557A3C-5E71-4260-B165-8D4D5CD183C7Q55471650-FA1F3C50-1C05-4C7E-BCE7-94356E28613F
P2860
Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Expression of the oligodendrog ...... ferent types of human gliomas.
@en
Expression of the oligodendrog ...... ferent types of human gliomas.
@nl
type
label
Expression of the oligodendrog ...... ferent types of human gliomas.
@en
Expression of the oligodendrog ...... ferent types of human gliomas.
@nl
prefLabel
Expression of the oligodendrog ...... ferent types of human gliomas.
@en
Expression of the oligodendrog ...... ferent types of human gliomas.
@nl
P2093
P2860
P356
P1476
Expression of the oligodendrog ...... ferent types of human gliomas.
@en
P2093
Akiko Ohnishi
Hirofumi Sawa
Kazuo Nagashima
Masumi Tsuda
Tomoo Itoh
Yoshinobu Iwasaki
Yutaka Sawamura
P2860
P304
P356
10.1093/JNEN/62.10.1052
P577
2003-10-01T00:00:00Z